Answer
Jul 31, 2025 - 09:41 AM
Do you have the same question? Follow this Question
Jul 31, 2025 - 09:41 AM
We’ve provided several answers to questions related to Sotyktu (Deucravacitinib) , see some other helpful Q&A related to this product.
Question: What are the risks associated with this medication in terms of cancer?
Answer: This medication may increase the risk of lymphomas, a type of white blood cell cancer. Being informed about potential risks helps patients make educated decisions and engage in regular health screenings for early detection.
Question: Does this medication interact with Adalimumab?
Answer: Yes, there is a potential drug-drug interaction with Adalimumab. It's important to discuss all medications with your healthcare provider to ensure safe and effective use, avoiding adverse interactions.